Verve Therapeutics Inc
NASDAQ:VERV

Watchlist Manager
Verve Therapeutics Inc Logo
Verve Therapeutics Inc
NASDAQ:VERV
Watchlist
Price: 3.9 USD -5.68% Market Closed
Market Cap: 346.3m USD

Intrinsic Value

The intrinsic value of one VERV stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.9 USD, Verve Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

VERV Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Verve Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
VERV
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for VERV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VERV?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Verve Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Verve Therapeutics Inc

Current Assets 542.8m
Cash & Short-Term Investments 524.3m
Receivables 3.3m
Other Current Assets 15.2m
Non-Current Assets 104.6m
PP&E 96.7m
Other Non-Current Assets 7.9m
Efficiency

Free Cash Flow Analysis
Verve Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Verve Therapeutics Inc

Revenue
32.3m USD
Operating Expenses
-261m USD
Operating Income
-228.7m USD
Other Expenses
30m USD
Net Income
-198.7m USD
Fundamental Scores

VERV Profitability Score
Profitability Due Diligence

Verve Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 1-Year Revenue Growth
ROE is Increasing
ROIC is Increasing
Negative Revenue Growth Forecast
hidden
Profitability
Score

Verve Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

VERV Solvency Score
Solvency Due Diligence

Verve Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Verve Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VERV Price Targets Summary
Verve Therapeutics Inc

Wall Street analysts forecast VERV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VERV is 23.17 USD with a low forecast of 15.15 USD and a high forecast of 33.6 USD.

Lowest
Price Target
15.15 USD
288% Upside
Average
Price Target
23.17 USD
494% Upside
Highest
Price Target
33.6 USD
762% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Verve Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VERV is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Ownership

VERV Insider Trading
Buy and sell transactions by insiders

VERV News

What is the Intrinsic Value of one VERV stock?

The intrinsic value of one VERV stock under the Base Case scenario is hidden USD.

Is VERV stock undervalued or overvalued?

Compared to the current market price of 3.9 USD, Verve Therapeutics Inc is hidden .

Back to Top